Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, has announced it entered into a secured debt
Hot Posts89- Page
For many U.S. veterans, independence is a source of pride. They’ve served their country, faced adversity, and built lives grounded in strength and resilience. However, as time passes, injuries, illnesses,
The University of Turin, through the Laboratory of Personal Identification and Forensic Odontology (LIPOF) of the Department of Public Health and Pediatric Sciences, has developed IDENTIKID, an innovative Identification Form for Children and Adolescents designed to assist families and authorities in
Keurig Dr Pepper (NASDAQ: KDP) announced two investment agreements related to the acquisition of JDE Peet’s and subsequent planned separation into two independent companies totaling US$7 billion, co-led by funds
Forensic ballistics serves as a key discipline within criminal investigations related to firearms. It is the scientific examination of bullets, ammunition and gunshot residues to link suspects to firearms and
Global law firm Clifford Chance has advised the lenders to international private equity firm Cinven in relation to the financing to support its acquisition of Smart Communications, a leading global
In an astonishing turn of events, French investigators solved the $100 million Louvre museum jewel heist in just days, setting a precedent for the power of forensic science in modern
Selling cognitive enhancers brings big opportunities. But still, it also brings legal risks that can sneak up fast. Each country has its own set of rules. Some ingredients get flagged
Herbert Smith Freehills Kramer’s (HSF Kramer) venture capital team has advised OpenSolar on its US$20 million Series B capital raise. Leading technology investors including Google, Titanium Ventures and 2150 Sustainability
Latham & Watkins advised Veracyte Inc., a leading cancer diagnostics company, in the context of the bankruptcy sale of the business of its French subsidiary, Veracyte SAS, to Helio Diagnostics
